FDA clears Zephyr's latest update to MATRx plus

2018 11 15 23 31 5737 Fda Logo V2 400

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to medical device company Zephyr Sleep Technologies' latest update to MATRx plus.

The clearance eliminates the requirement for a nasal cannula during a sleep theranostic test and makes setting up the take-home Treatment Planning test simpler. Patients now only need a single fingertip pulse oximetry probe for the test.

All existing MATRx plus users who are Connected Program subscribers will receive the update at no additional charge.

Page 1 of 271
Next Page